Mucopolysaccharidosis VII
"Mucopolysaccharidosis VII" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase.
| Descriptor ID |
D016538
|
| MeSH Number(s) |
C16.320.565.202.715.675 C16.320.565.595.600.675 C17.300.550.575.675 C18.452.648.202.715.675 C18.452.648.595.600.675
|
| Concept/Terms |
Mucopolysaccharidosis VII- Mucopolysaccharidosis VII
- Mucopolysaccharidosis VIIs
- VIIs, Mucopolysaccharidosis
- Sly Disease
- Disease, Sly
- beta-Glucuronidase Deficiency
- Deficiencies, beta-Glucuronidase
- Deficiency, beta-Glucuronidase
- beta Glucuronidase Deficiency
- beta-Glucuronidase Deficiencies
- GUSB Deficiency
- Deficiencies, GUSB
- Deficiency, GUSB
- GUSB Deficiencies
- Mucopolysaccharidosis Type VII
- Mucopolysaccharidosis Type VIIs
- Type VII, Mucopolysaccharidosis
- Type VIIs, Mucopolysaccharidosis
- Mucopolysaccharidosis 7
- Sly Syndrome
- Syndrome, Sly
|
Below are MeSH descriptors whose meaning is more general than "Mucopolysaccharidosis VII".
Below are MeSH descriptors whose meaning is more specific than "Mucopolysaccharidosis VII".
This graph shows the total number of publications written about "Mucopolysaccharidosis VII" by people in this website by year, and whether "Mucopolysaccharidosis VII" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mucopolysaccharidosis VII" by people in Profiles.
-
The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII. Mol Genet Metab. 2020 03; 129(3):219-227.
-
Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII. Circulation. 2004 Aug 17; 110(7):815-20.